Detalhe da pesquisa
1.
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion.
Oncologist
; 27(1): 7-12, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305107
2.
New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network.
Eur J Cancer Care (Engl)
; 31(6): e13736, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039607
3.
Pembrolizumab in lung cancer: current evidence and future perspectives.
Future Oncol
; 15(29): 3327-3336, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432705
4.
Angiogenesis Inhibitors in NSCLC.
Int J Mol Sci
; 18(10)2017 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934120
5.
Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working.
Explor Target Antitumor Ther
; 5(2): 260-277, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751383
6.
Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis.
JCO Oncol Pract
; 19(3): e315-e325, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383923
7.
BRAF Inhibitors in Non-Small Cell Lung Cancer.
Cancers (Basel)
; 14(19)2022 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230797
8.
Lurbinectedin in small cell lung cancer.
Front Oncol
; 12: 932105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36110944
9.
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
J Thorac Oncol
; 17(9): 1086-1097, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659580
10.
Gefitinib in non small cell lung cancer.
J Biomed Biotechnol
; 2011: 815269, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21660144
11.
Debulking mastectomy with electrochemotherapy: a case report of no surgery approach to recurrent breast cancer.
Transl Cancer Res
; 10(2): 1144-1149, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35116441
12.
Angiogenesis Inhibitors in Small Cell Lung Cancer.
Front Oncol
; 11: 655316, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34123809
13.
RET Inhibitors in Non-Small-Cell Lung Cancer.
Cancers (Basel)
; 13(17)2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503226
14.
Immunotherapy in Small Cell Lung Cancer.
Cancers (Basel)
; 12(9)2020 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32899891
15.
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer.
Explor Target Antitumor Ther
; 1(2): 117-130, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-36046069
16.
The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer.
Expert Opin Drug Saf
; 19(7): 775-783, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400223
17.
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Transl Cancer Res
; 8(Suppl 1): S16-S22, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117061
18.
Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials.
Crit Rev Oncol Hematol
; 65(2): 164-71, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17702595
19.
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.
J Clin Oncol
; 36(25): 2585-2592, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028656
20.
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
Lung Cancer
; 108: 15-21, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28625627